[{"AccountsPayableCurrent_0_Q3_USD":4108000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":522000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":26971000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-2000.0,"OperatingLeaseExpense_3_Q3_USD":1100000.0,"OperatingLeaseExpense_1_Q3_USD":400000.0,"OperatingIncomeLoss_3_Q3_USD":-31393000.0,"OperatingIncomeLoss_1_Q3_USD":-16133000.0,"OperatingExpenses_3_Q3_USD":32518000.0,"OperatingExpenses_1_Q3_USD":16133000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"NetIncomeLoss_3_Q3_USD":-32764000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-24880000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-24793000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":301795000.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":-2000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-2000.0,"MarketableSecuritiesCurrent_0_Q3_USD":24052000.0,"LongTermDebtNoncurrent_0_Q3_USD":2122000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":938000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":938000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":300000.0,"NetIncomeLoss_1_Q3_USD":-17335000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":468000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"UnbilledReceivablesCurrent_0_Q3_USD":2000000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":3158000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":214708000.0,"StockholdersEquity_0_Q3_USD":327520000.0,"ShortTermBorrowings_0_Q3_USD":245000.0,"ShareBasedCompensation_3_Q3_USD":3901000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1125000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-87512000.0,"RestrictedCashCurrent_0_Q3_USD":150000.0,"RestrictedCash_0_Q3_USD":348000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":24292000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":11689000.0,"RepaymentsOfLongTermCapitalLeaseObligations_3_Q3_USD":99000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1396000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":2416000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":83341000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":216182000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2976000.0,"RestrictedCashNoncurrent_0_Q3_USD":198000.0,"LongTermDebt_0_Q3_USD":2367000.0,"LiabilitiesCurrent_0_Q3_USD":12720000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":342382000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-17337000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":252122000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":311958000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":311610000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":335030000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":335032000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-32766000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":2000.0,"Assets_0_Q3_USD":342382000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2551233.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":2551233.0,"AmortizationOfFinancingCosts_3_Q3_USD":78000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3901.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3158.0,"AdditionalPaidInCapital_0_Q3_USD":415030000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-2000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":8367000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-218000.0,"AssetsCurrent_0_Q3_USD":340788000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":2644000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":277000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":20000.0,"Liabilities_0_Q3_USD":14862000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":377000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2433000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2506000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2582000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2286000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":19113000.0,"InterestPaidNet_3_Q3_USD":49000.0,"InterestExpense_3_Q3_USD":114000.0,"InterestExpense_1_Q3_USD":60000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2612000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-5000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-1125000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":4242000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1363000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":8226000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4444000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":1318000.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":1162000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":19700000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-8.12,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.3,"DepreciationAndAmortization_3_Q3_USD":505000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":7551128.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":4035590.0,"Ticker":"DICE","CIK":"1645569","name":"DICE THERAPEUTICS, INC.","OfficialName":"DICE Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"808594427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]